Clinical updates from the EHA 2017


July 24, 2017

  • Share this post:

The 22nd European Hematology Association (EHA) took place in Madrid, Spain, on 22-25 June 2017.

An international multidisciplinary panel discussed a selection of topics and new data on hematology during a live program. They gave an answer to what this newly acquired knowledge means for clinical practice.

Topics

  • Immunotherapy for childhood ALL
  • CML treatment in children and adults
  • Treatment reduction in Hodgkin Lymphoma
  • Fertility preservation
  • The role of the microbiome to improve survival after allogeneic stem cell transplantation
  • Prof. Harry Schouten, MD – hematologist, Maastricht UMC+, Maastricht, The Netherlands

Speakers

  • Thamer Sliwa, MD – hematologist, Hanusch Krankenhaus, Vienna, Austria
  • Prof. Michel Zwaan, MD – pediatric hematologist, EMC, Rotterdam, The Netherlands

Moderator

  • Prof. Harry Schouten, MD – hematologist, Maastricht UMC+, Maastricht, The Netherlands

This program was financially supported by Novartis.

Related articles